New Guidelines for Home Oxygen Therapy in Pediatric Patients
The American Thoracic Society (ATS) has just released the first national clinical practice guidelines for home oxygen therapy in children.
Children with SMA1, the number one genetic killer of babies under 2 years of age, fail to meet motor milestones and typically die or require permanent mechanical ventilation by age 2.
Altered immune and inflammatory responses hinder clearance of bacterial infections.
Treated immune cells function properly to kill more bacteria, depending on the treatment and the bacteria.
A protein that triggers an imbalance of mucous and ciliated cells in patients with chronic lung disease could be a target for treatments to restore airways.
Multiple steps lead to better control of disease, fewer emergency department visits and $5 million in savings.
In 1999, the Section of Pulmonary Medicine at Nationwide Children’s was designated as an American Lung Association Asthma Clinical Research Center, one of 18 selected participants, only five of which are pediatric.
Pulmonary Medicine at Nationwide Children’s Hospital has been involved in research related to cystic fibrosis (CF) since the early 1990s.
According to UNICEF data, the death rate for children under the age of 5 years is 43 per 1,000 live births in India. This means that 563,752 children will die this year, many without proper diagnosis of their diseases.
You Might Also Be Interested In
Sign Up for PediatricsOnline
Subscribe to PediatricsOnline, a bi-monthly electronic newsletter featuring medical stories, clinical case studies, research announcements and other news from Nationwide Children's Hospital.
We provide care for children and adults with congenital respiratory disorders including asthma, cystic fibrosis, sleep-related breathing disorders, advanced lung disease, lung transplant, and the management of chronic mechanical ventilation.